{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:24:18Z","timestamp":1791419058881,"version":"4.3.3"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T00:00:00Z","timestamp":1539302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA102667"],"award-info":[{"award-number":["CA102667"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["D43 153707"],"award-info":[{"award-number":["D43 153707"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIH National Institute of Allergy and Infectious Diseases","doi-asserted-by":"crossref","award":["5T32AI007405-27"],"award-info":[{"award-number":["5T32AI007405-27"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,23]]},"DOI":"10.1093\/infdis\/jiy601","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T03:21:44Z","timestamp":1539055304000},"page":"955-963","source":"Crossref","is-referenced-by-count":24,"title":["Differences in the Epstein-Barr Virus gp350 IgA Antibody Response Are Associated With Increased Risk for Coinfection With a Second Strain of Epstein-Barr Virus"],"prefix":"10.1093","volume":"219","author":[{"given":"Nicholas A","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C","family":"Baresel","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conner L","family":"Jackson","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney","family":"Ogolla","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora"},{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunice N","family":"Toko","sequence":"additional","affiliation":[{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Heit","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, State University of New York Upstate Medical University, Syracuse"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwan","family":"Piriou","sequence":"additional","affiliation":[{"name":"M\u00e9decins Sans Fronti\u00e8res, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odada P","family":"Sumba","sequence":"additional","affiliation":[{"name":"Centre for Global Health Research, Kenya Medical Research Institute, Kisumu, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap M","family":"Middeldorp","sequence":"additional","affiliation":[{"name":"Department of Pathology, Vrije University Medical Center, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn L","family":"Colborn","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemary","family":"Rochford","sequence":"additional","affiliation":[{"name":"Department of Immunology and Microbiology, University of Colorado Anschutz Medical Campus, Aurora"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,12]]},"reference":[{"key":"key\n\t\t\t\t2019031513363810700_CIT0001","first-page":"211","article-title":"Infectious mononucleosis","volume":"390","author":"Dunmire","year":"2015","journal-title":"Curr Top Microbiol Immunol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0002","doi-asserted-by":"crossref","first-page":"107fs7","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0003","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/infdis\/jix363","article-title":"Epstein-Barr virus type 2 infects T cells in healthy Kenyan children","volume":"216","author":"Coleman","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0004","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1093\/infdis\/jiv290","article-title":"Breast milk as a potential source of Epstein-Barr virus transmission among infants living in a malaria-endemic region of Kenya","volume":"212","author":"Daud","year":"2015","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0005","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1099\/0022-1317-68-11-2853","article-title":"New type B isolates of Epstein-Barr virus from Burkitt\u2019s lymphoma and from normal individuals in endemic areas","volume":"68","author":"Young","year":"1987","journal-title":"J Gen Virol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0006","first-page":"3949","article-title":"Direct Epstein-Barr virus (EBV) typing on peripheral blood mononuclear cells: no association between EBV type 2 infection or superinfection and the development of acquired immunodeficiency syndrome-related non-Hodgkin\u2019s lymphoma","volume":"93","author":"van Baarle","year":"1999","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0007","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/ijc.2910220305","article-title":"Primary Epstein-Barr virus infections in African infants. II. Clinical and serological observations during seroconversion","volume":"22","author":"Biggar","year":"1978","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0008","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/139.5.553","article-title":"Primary infection with Epstein-Barr virus in infants in the United States: clinical and serologic observations","volume":"139","author":"Fleisher","year":"1979","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0009","doi-asserted-by":"crossref","first-page":"e1004746","DOI":"10.1371\/journal.ppat.1004746","article-title":"Early virological and immunological events in asymptomatic Epstein-Barr virus infection in African children","volume":"11","author":"Jayasooriya","year":"2015","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0010","doi-asserted-by":"crossref","first-page":"pii:e00382-17","DOI":"10.1128\/JVI.00382-17","article-title":"Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases","volume":"91","author":"Abbott","year":"2017","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0011","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1128\/JCM.29.6.1215-1220.1991","article-title":"Reactivation of Epstein-Barr virus during early infection with human immunodeficiency virus","volume":"29","author":"Rahman","year":"1991","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0012","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/CVI.00674-15","article-title":"Kinetics of Epstein-Barr virus (EBV) neutralizing and virus-specific antibodies after primary infection with EBV","volume":"23","author":"Bu","year":"2016","journal-title":"Clin Vaccine Immunol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0013","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.81.14.4510","article-title":"Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2","volume":"81","author":"Fingeroth","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0014","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1073\/pnas.82.5.1490","article-title":"gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor","volume":"82","author":"Frade","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0015","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1128\/JVI.61.5.1416-1420.1987","article-title":"Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV\/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d","volume":"61","author":"Nemerow","year":"1987","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0016","doi-asserted-by":"crossref","first-page":"4452","DOI":"10.1128\/JVI.62.12.4452-4464.1988","article-title":"Soluble gp350\/220 and deletion mutant glycoproteins block Epstein-Barr virus adsorption to lymphocytes","volume":"62","author":"Tanner","year":"1988","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0017","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2009.06.013","article-title":"Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay","volume":"391","author":"Sashihara","year":"2009","journal-title":"Virology"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0018","doi-asserted-by":"crossref","first-page":"pii:e01562-16","DOI":"10.1128\/JVI.01562-16","article-title":"High Epstein-Barr virus load and genomic diversity are associated with generation of gp350-specific neutralizing antibodies following acute infectious mononucleosis","volume":"91","author":"Weiss","year":"2016","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0019","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1038\/cti.2016.48","article-title":"Prospective studies of infectious mononucleosis in university students","volume":"5","author":"Grimm","year":"2016","journal-title":"Clin Transl Immunology"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0020","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1038\/cti.2014.27","article-title":"Epstein-Barr virus vaccines","volume":"4","author":"Cohen","year":"2015","journal-title":"Clin Transl Immunology"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0021","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJM197606172942501","article-title":"Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx","volume":"294","author":"Niederman","year":"1976","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0022","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/infdis\/jir872","article-title":"Early age at time of primary Epstein-Barr virus infection results in poorly controlled viral infection in infants from Western Kenya: clues to the etiology of endemic Burkitt lymphoma","volume":"205","author":"Piriou","year":"2012","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0023","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/infdis\/jiv525","article-title":"Impact of Plasmodium falciparum coinfection on longitudinal Epstein-Barr virus kinetics in Kenyan children","volume":"213","author":"Reynaldi","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0024","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/sj.bjc.6605947","article-title":"Microgeographic variations in Burkitt\u2019s lymphoma incidence correlate with differences in malnutrition, malaria and Epstein-Barr virus","volume":"103","author":"Sumba","year":"2010","journal-title":"Br J Cancer"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0025","doi-asserted-by":"crossref","first-page":"7298","DOI":"10.1128\/JVI.67.12.7298-7306.1993","article-title":"Epstein-Barr virus recombinants from overlapping cosmid fragments","volume":"67","author":"Tomkinson","year":"1993","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0026","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/jmv.21485","article-title":"Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya","volume":"81","author":"Piriou","year":"2009","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0027","doi-asserted-by":"crossref","first-page":"4932","DOI":"10.1128\/JVI.03269-14","article-title":"Peptides designed to spatially depict the Epstein-Barr virus major virion glycoprotein gp350 neutralization epitope elicit antibodies that block virus-neutralizing antibody 72A1 interaction with the native gp350 molecule","volume":"89","author":"Tanner","year":"2015","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0028","article-title":"Hands-on tutorial for piecewise linear mixed-effects models using SAS\u00ae PROC MIXED (ST08)","volume-title":"Pharmaceutical SAS Users Group Conference Proceedings. Shanghai, China, 4\u20135 September","author":"Huang"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0029","first-page":"20","article-title":"Segmented: an R package to fit regression models with broken-line relationships","volume":"8","author":"Muggeo","year":"2008","journal-title":"R News"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0030","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1002\/sim.1545","article-title":"Estimating regression models with unknown break-points","volume":"22","author":"Muggeo","year":"2003","journal-title":"Stat Med"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0031","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1093\/infdis\/jiw396","article-title":"Modeling of EBV infection and antibody responses in Kenyan infants with different levels of malaria exposure shows maternal antibody decay is a major determinant of early EBV infection","volume":"214","author":"Reynaldi","year":"2016","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0032","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/infdis\/jit093","article-title":"Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women","volume":"207","author":"Slyker","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0033","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1086\/505400","article-title":"A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis","volume":"43","author":"Crawford","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0034","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0065-230X(08)60714-9","article-title":"Molecular epidemiology of Epstein-Barr virus infection","volume":"67","author":"Gratama","year":"1995","journal-title":"Adv Cancer Res"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0035","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nri2322","article-title":"The regulation of IgA class switching","volume":"8","author":"Cerutti","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0036","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/(SICI)1097-0215(19981023)79:5<481::AID-IJC6>3.0.CO;2-X","article-title":"The Epstein-Barr virus (EBV) major envelope glycoprotein gp350\/220-specific antibody reactivities in the sera of patients with different EBV-associated diseases","volume":"79","author":"Xu","year":"1998","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0037","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1128\/JVI.71.1.519-526.1997","article-title":"Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus","volume":"71","author":"Gan","year":"1997","journal-title":"J Virol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0038","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1093\/infdis\/jiy250","article-title":"Evaluation of total and IgA-specific antibody targeting Epstein-Barr virus glycoprotein 350 and nasopharyngeal carcinoma risk","volume":"218","author":"Coghill","year":"2018","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0039","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1128\/JCM.36.12.3740-3740.1998","article-title":"Clinical relevance of serum immunoglobulin A antibodies to Epstein-Barr virus envelope glycoprotein gp350 in nasopharyngeal carcinoma patients","volume":"36","author":"Xu","year":"1998","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0040","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1182\/blood-2007-06-093278","article-title":"On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis","volume":"111","author":"Hadinoto","year":"2008","journal-title":"Blood"},{"key":"key\n\t\t\t\t2019031513363810700_CIT0041","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1084\/jem.20121437","article-title":"MHC II tetramers visualize human CD4+ T cell responses to Epstein-Barr virus infection and demonstrate atypical kinetics of the nuclear antigen EBNA1 response","volume":"210","author":"Long","year":"2013","journal-title":"J Exp Med"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/219\/6\/955\/28080220\/jiy601.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T09:53:16Z","timestamp":1605174796000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/219\/6\/955\/5127265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,12]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,10,12]]},"published-print":{"date-parts":[[2019,2,23]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiy601","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,3,15]]},"published":{"date-parts":[[2018,10,12]]}}}